Javelin Pharmaceuticals has completed accrual of subjects in the last of four planned Phase I human pharmacokinetic (PK) studies needed to support its intended filing of a new drug application in 2009, for its intranasal ketamine product candidate, PMI-150.
Javelin Pharmaceuticals recently completed accrual of subjects in the last of four planned Phase 1 human pharmacokinetic (PK) studies needed to support its intended filing of a New Drug Application (NDA) next year for its intranasal ketamine product candidate, PMI-150.
Javelin Pharmaceuticals (AMEX: JAV) announced today that it recently completed accrual of subjects in the last of four planned Phase 1 human pharmacokinetic (PK) studies needed to support its intended filing of a New Drug Application (NDA) next year for its intranasal ketamine product candidate, PMI-150.
A U.S. federal judge Thursday granted Pfizer Inc.'s motion to dismiss a shareholder lawsuit that alleged the company hid information and made misleading claims about a failed experimental cholesterol
Deutsche Bank has joined the small handful of firms offering exchange-traded structured notes and other firms, including JPMorgan , are expected to follow shortly.
Nine findings in the Town of Carrizozo audit for the 2005-06 fiscal year were made public in a special council meeting Tuesday, noting that several of the findings were in direct violation of town ordinances and state statutes.
Pacific Coast National Bancorp ("Company") (OTCBB: PCST.OB) the parent corporation of Pacific Coast National Bank ("Bank"), today announced significant improvement towards achieving profitability, reporting a net loss for 2007 of $4.0 million or $1.77 per share, as compared to a $4.2 million or $1.84 per share net loss for 2006. The decline in loss per share was primarily due to a 73% increase
View comments
Hide comments
